Cure My Disease

Don't miss your cure!

 Log in / Sign up

Russian breast cancer study reveals Real-World treatment patterns

NCT ID NCT04943497

Completed Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observed over 2,400 women in Russia with advanced HR+/HER2- breast cancer to see how well different treatments work in everyday medical practice. Researchers tracked how long patients stayed on their therapy before it stopped working or caused side effects. The goal was to understand real-world outcomes, not to test a new drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm hormone receptor-positive breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

  • Novartis Investigative Site

    Syktyvkar, Komi, 167904, Russia

  • Novartis Investigative Site

    Sochi, Russian Federation, 354057, Russia

  • Novartis Investigative Site

    Kaluga, Russia, 248007, Russia

  • Novartis Investigative Site

    Surgut, Tymen Area, 628402, Russia

  • Novartis Investigative Site

    Arkhangelsk, 163045, Russia

  • Novartis Investigative Site

    Barnaul, 656045, Russia

  • Novartis Investigative Site

    Belgorod, 308010, Russia

  • Novartis Investigative Site

    Bryansk, 241028, Russia

  • Novartis Investigative Site

    Cheboksary, 428020, Russia

  • Novartis Investigative Site

    Chelyabinsk, 454087, Russia

  • Novartis Investigative Site

    Cherkessk, 369000, Russia

  • Novartis Investigative Site

    Chita, 672027, Russia

  • Novartis Investigative Site

    Irkutsk, 664035, Russia

  • Novartis Investigative Site

    Ivanovo, 153040, Russia

  • Novartis Investigative Site

    Izhevsk, 426009, Russia

  • Novartis Investigative Site

    Kaliningrad, 236016, Russia

  • Novartis Investigative Site

    Khabarovsk, 680042, Russia

  • Novartis Investigative Site

    Khanty-Mansiysk, 628012, Russia

  • Novartis Investigative Site

    Kirov, 610021, Russia

  • Novartis Investigative Site

    Kostroma, 156005, Russia

  • Novartis Investigative Site

    Krasnodar, 350040, Russia

  • Novartis Investigative Site

    Krasnoyarsk, 660022, Russia

  • Novartis Investigative Site

    Moscow, 105005, Russia

  • Novartis Investigative Site

    Moscow, 111123, Russia

  • Novartis Investigative Site

    Moscow, 115304, Russia

  • Novartis Investigative Site

    Moscow, 115522, Russia

  • Novartis Investigative Site

    Moscow, 129110, Russia

  • Novartis Investigative Site

    Moscow, 143423, Russia

  • Novartis Investigative Site

    Moscow Region Balas, 143900, Russia

  • Novartis Investigative Site

    Nal'chik, 360051, Russia

  • Novartis Investigative Site

    Nizhny Novgorod, 603081, Russia

  • Novartis Investigative Site

    Novosibirsk, 630108, Russia

  • Novartis Investigative Site

    Odintsovo, 143003, Russia

  • Novartis Investigative Site

    Omsk, 644013, Russia

  • Novartis Investigative Site

    Perm, 614066, Russia

  • Novartis Investigative Site

    Podolsk, 142110, Russia

  • Novartis Investigative Site

    Pyatigorsk, 357502, Russia

  • Novartis Investigative Site

    Rostov-on-Don, 344006, Russia

  • Novartis Investigative Site

    Saint Petersburg, 191104, Russia

  • Novartis Investigative Site

    Saint Petersburg, 194214, Russia

  • Novartis Investigative Site

    Saint Petersburg, 197758, Russia

  • Novartis Investigative Site

    Saransk, 430032, Russia

  • Novartis Investigative Site

    Saratov, 410053, Russia

  • Novartis Investigative Site

    Sestroretsk, 197706, Russia

  • Novartis Investigative Site

    Sevastopol’, 299045, Russia

  • Novartis Investigative Site

    Severodvinsk, 450054, Russia

  • Novartis Investigative Site

    Simferopol, 295023, Russia

  • Novartis Investigative Site

    Tambov, 392000, Russia

  • Novartis Investigative Site

    Tula, 300040, Russia

  • Novartis Investigative Site

    Tver', 170008, Russia

  • Novartis Investigative Site

    Tyumen, 625041, Russia

  • Novartis Investigative Site

    Ufa, 450054, Russia

  • Novartis Investigative Site

    Vladikavkaz, 362002, Russia

  • Novartis Investigative Site

    Vladivostok, 690105, Russia

  • Novartis Investigative Site

    Voronezh, 394036, Russia

  • Novartis Investigative Site

    Yekaterinburg, 620027, Russia

  • Novartis Investigative Site

    Yekaterinburg, 620036, Russia

  • Novartis Investigative Site

    Yuzhno-Sakhalinsk, 693010, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.